@misc{indiciae1f2417265901,
  title = {SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis},
  author = {Njouendou, A. J. and Tiofack, A. A. Z. and Kenfack, R. N. and Ananga, S. N. and Bell, E. H. M. D. and Simo, G. and Hoheisel, J. D. and Siveke, J. T. and Lueong, S. S.},
  year = {2022},
  doi = {10.1101/2022.06.09.495487},
  url = {https://www.biorxiv.org/content/10.1101/2022.06.09.495487v1},
  note = {Source identifier: 10.1101/2022.06.09.495487}
}